Journal article icon

Journal article

Pyridostigmine, an Acetylcholinesterase Inhibitor, Stimulates Growth Hormone Release, but has no Effect on Basal Thyrotrophin or Adrenocorticotrophin Levels, or the Thyrotrophin Response to Thyrotrophin-Releasing Hormone.

Abstract:

Abstract Pyridostigmine, an acetylcholinesterase inhibitor, stimulates growth hormone (GH) release and is thought to act by inhibiting hypothalamic somatostatin release. There are few data concerning the effect of pyridostigmine on other pituitary hormones apart from GH. We have studied the effect of pyridostigmine on basal GH, thyrotrophin (TSH), prolactin, adrenocorticotrophin and cortisol release, and thyrotrophin-releasing hormone (TRH)-stimulated TSH and prolactin release, in two studies...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Freeman, E More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, OCDEM
Journal:
Journal of neuroendocrinology
Volume:
2
Issue:
4
Pages:
429-432
Publication date:
1990-08-05
DOI:
EISSN:
1365-2826
ISSN:
0953-8194
URN:
uuid:f1658216-0cd0-4bb0-ac36-786928e27823
Source identifiers:
138740
Local pid:
pubs:138740
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP